Reed Smith LLP handles the full spectrum of regulatory issues in the life sciences sector, with notable expertise in assisting clients looking to enter the digital healthcare arena, in addition to advising on FDA rules concerning clinical trials and marketing. June 2023 saw the firm strengthen its position at the intersection of transactional and regulatory issues with the arrival of Brian Bewley from Manatt, Phelps & Phillips, LLP, adding to Nancy Halstead‘s expertise in regulations governing the use of technology in the life sciences and healthcare industries. Scot Hasselman spearheads the firm’s life sciences team, having built up a practice covering government investigations, transactions and licensing deals.
Testimonials
Collated independently by Legal 500 research team.
- 'Incredibly customer-focused, timely, detailed work. No project too small, they never pass off work to staff I don't know, I always work with the same team, which is wonderful. I feel like they care about my organization's needs. Reed Smith works very well together internally and that shows.'